Evidence map›Paper›PMID 11160396›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Regulation of neuregulin expression in the injured rat brain and cultured astrocytes.

Y Tokita, H Keino, F Matsui, S Aono, H Ishiguro, S Higashiyama, A Oohira

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Elevated neuregulin-1Endocrine and metabolic science · 2021
    Article
  5. Review
  6. Article
  7. Activation and Role of Astrocytes in Ischemic Stroke.Frontiers in cellular neuroscience · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Epilepsy-on-a-Chip System for Antiepileptic Drug Discovery.IEEE transactions on bio-medical engineering · 2019
    Article
  12. Article
  13. Article
  14. Neuregulin in Health and Disease.International journal of brain disorders and treatment · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Y TokitaDepartment of Perinatology, Institute for Developmental Research, Kasugai, Aichi 480-0392, Japan. tokita@inst-hsc.pref.aichi.jp
H Keino
F Matsui
S Aono
H Ishiguro
S Higashiyama
A Oohira
Aichi Developmental Disability Center · JPFujita Health University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this report, we investigated whether reactive astrocytes produce neuregulins (glial growth factor 2/heregulin/acetylcholine receptor-inducing activity or neu differentiation factor) and its putative receptors, ErbB2 and ErbB3 tyrosine kinases, in the injured CNS in vivo. Significant immunoreactivities with anti-neuregulin, anti-ErbB2, and anti-ErbB3 antibodies were detected on astrocytes at the injured site 4 d after injury to the adult rat cerebral cortex. To elucidate the mechanisms for the upregulation of neuregulin expression in astrocytes, primary cultured astrocytes were treated with certain reagents, including forskolin, that are known to elevate the intracellular level of cAMP and induce marked morphological changes in astrocytes. Western blot analysis showed that the expression of a 52 kDa membrane-spanning form of a neuregulin protein was enhanced in cultured astrocytes after administration of forskolin. The upregulation of glial fibrillary acidic protein was also observed in astrocytes treated with forskolin. In contrast, inactivation of protein kinase C because of chronic treatment with phorbol ester 12-O-tetradecanoyl phorbol 13-acetate downregulated the expression of the 52 kDa isoform, although other splice variants with apparent molecular sizes of 65 and 60 kDa were upregulated. These results suggest that the enhancement of neuregulin expression at injured sites is induced, at least in part, by elevation in intracellular cAMP levels and/or a protein kinase C signaling pathway. The neuregulin expressed on reactive astrocytes may stimulate their proliferation and support the survival of neurons surrounding cortical brain wounds in vivo.

Indexed as

AnimalsAstrocytesBrain InjuriesCells, CulturedCerebral CortexCHO CellsColforsinCricetinaeCyclic AMPCyclic AMP-Dependent Protein KinasesDisease Models, AnimalErb-b2 Receptor Tyrosine KinasesGlial Fibrillary Acidic ProteinHead Injuries, PenetratingNeuregulinsProtein IsoformsColforsinCyclic AMPCyclic AMP-Dependent Protein KinasesErb-b2 Receptor Tyrosine KinasesGlial Fibrillary Acidic ProteinNeuregulinsProtein IsoformsProtein Kinase CReceptor, ErbB-3Tetradecanoylphorbol Acetate

Identifiers

PMID11160396
PMCPMC6762219
OpenAlexW1607385122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.